Endocytosed lysophosphatidylcholine, through the scavenger receptor, plays an essential role in oxidized low-density lipoprotein-induced macrophage proliferation

Trends in Cardiovascular Medicine

Volumn 8, Issue 3, 1998, Pages 119-124

  Sakai, Masakazu ^a   Shichiri, Motoaki ^a   Hakamata, Hideki ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; ENDOCYTOSIS; GROWTH STIMULATION; LIGAND BINDING; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY; VASCULAR SMOOTH MUSCLE;

EID: 0031949190     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00139-4     Document Type: Article

References (55)

1. Acton SL, Scherer PE, Lodish HF, et al.: 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 269:21,003-21,009.
2. Aviram M: 1989. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb Res 53:561-567.
3. 2 in signal transduction through protein kinase C. Proc Natl Acad Sci USA 89:6447-6451.
4. Bitterman PB, Saltman LE, Adelberg S, Ferrans VJ, Crystal RG: 1984. Alveolar macrophage replication: one mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest 74:460-469.
5. Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL: 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramolec Struct 13:67-81.
6. Chai Y-C, Howe PH, DiCoreleto E, Chisolm GM: 1996. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. J Biol Chem 271:17,791-17,797.
7. Chen BD-M, Clark CR: 1986. Interleukin 3 regulates the in vivo proliferation of both blood monocytes and peripheral exudate macrophages: synergism between a macrophage-specific colony-stimulating factor. J Immunol 137:563-570.
8. Chen BD-M, Clark CR, Chou DL: 1988. Granulocyte/macrophage colony stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony stimulating factor. Blood 71:997-1002.
9. Coggle JE, Tarling JD: 1984. The proliferation kinetics of pulmonary alveolar macrophages. J Leukoc Biol 35:317-325.
10. Endemann G, Stanton LW, Madden KS, et al.: 1993. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11,811-11,816.
11. Evans R, Cullen RT: 1984. In situ proliferation of intratumor macrophages. J Leukoc Biol 35:561-572.
12. Furth R van: 1989. Origin and turnover of monpcytes and macrophages. Curr Topic Pathol 78:125-150.
13. Furth R van, Diesselhoff-den Dulk MMC: 1984. Dual origin of mouse spleen macrophages. J Exp Med 160:1273-1283.
14. Gordon D, Reidy MA, Benditt EP, Schwartz SM: 1990. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87:4600-4604.
15. Hamilton JA: 1983. Glucocorticoids and prostaglandins inhibit the induction of macrophage DNA synthesis by macrophage growth factor and phorbol ester. J Cell Physiol 115:67-74.
16. Hamilton JA, Dientsman SR: 1981. Induction of macrophage DNA synthesis by phorbol esters. J Cell Physiol 106:445-450.
17. Kodama T, Freeman M, Rohrer L, et al.: 1990. Type I macrophage scavenger receptor contains α-helical collagen-like coiled coils. Nature 343:531-535.
18. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-162.
19. Kume N, Gimbrone MA Jr: 1994. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93: 907-911.
20. Kume N, Cybulsky MI, Gimbrone MA Jr: 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138-1144.
21. Matsumura T, Sakai M, Kobori S, et al.: 1997. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low density lipoprotein-induced macrophage growth. Arterioscler Thromb Vasc Biol 17:3013-3020.
22. Menschikowski M, Kasper M, Lattke P, et al.: 1995. Secretory group-II phospholipase A2 in human atherosclerotic plaques. Atherosclerosis 118:173-181.
23. Morel DW, DiCorleto PE, Chisolm GM: 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Atherosclerosis 4:357-364.
24. Naito M, Takahashi K: 1991. The role of Kupffer cells in glucan-induced granuloma formation in the liver of mice depleted of blood monocytes by administration of strontium-89. Lab Invest 64:664-674.
25. Nishizuka Y: 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
26. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al.: 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86:1372-1376.
27. Parthasarathy S, Barnett J: 1990. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc Natl Acad Sci USA 87:9741-9745.
28. Quinn MT, Parthasarathy S, Steinberg D: 1988. Lysophosphatidylcholine: a chemotactic factor for human monocyte and its potential role in atherogenesis. Proc Natl Acad Sci USA 85:2085-2809.
29. Rajavashisth TB, Andalibi A, Territo MC, et al.: 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 244:254-257.
30. Ramprasad MP, Fischer W, Witztum JL, et al.: 1995. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92:9580-9584.
31. Rosenfeld ME, Ross R: 1990. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10:680-687.
32. Ross R: 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
33. Sakai M, Miyazaki A, Hakamata H, et al.: 1994. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 269:31,430-31,435.
34. Sakai M, Miyazaki A, Hakamata H, et al.: 1996a. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 16:600-605.
35. Sakai M, Miyazaki A, Hakamata H, Kobori S, Shichiri M, Horiuchi S: 1996b. Endocytic uptake of lysophosphatidylcholine mediated by macrophage scavenger receptor plays a major role in oxidized low density lipoprotein-induced macrophage growth. J Arterioscler Thromb 2:81-86.
36. Sakai M, Miyazaki A, Hakamata H, et al.: 1996c. The scavenger receptor serve as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J Biol Chem 271:27,346-27,352.
37. Sakai M, Matsumura T, Biwa T, et al.: 1997. Role of the macrophage scavenger receptor for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage growth. Ann NY Acad Sci 811:378-384.
38. Sato Y, Kobori S, Sakai M, Yano T, et al.: 1996. Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-β activation. Atherosclerosis 125:15-26.
39. Sawamura T, Kume N, Aoyama T, et al.: 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73-77.
40. Sawyer RT: 1986. The significance of local resident pulmonary alveolar macrophage proliferation to population renewal. J Leukoc Biol 39:77-87.
41. Sawyer RT, Strausbauch PH, Volkman A: 1982. Resident macrophage proliferation in mice depleted of blood monocytes by Strontium-89. Lab Invest 46:165-170.
42. Spagnoli LG, Orlandi A, Santeusanio G: 1991. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis 88:87-92.
43. Stanley ER, Guilbert LJ, Tushinski RJ, Bartlemets SH: 1983. CSF-1: a mononuclear phagocyte lineage specific hemopoietic growth factor. J Cell Biol 21:151-159.
44. Stanton LW, White RT, Bryant CM, et al.: 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem 267:22,446-22,451.
45. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: 1989. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924.
46. Steinbrecher UP, Prichard PH: 1989. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res 30:305-315.
47. Stewart CC: 1983. Local proliferation of mononuclear phagocytes in tumor. J Leukoc Biol 34:23-27.
48. Stiko-Rahm A, Hultgardh-Nilsson A, Regnstrom J, Hamsten A, Nilsson J: 1992. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb 12:1099-1109.
49. Suzuki H, Kurihara Y, Takeya M, et al.: 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-296.
50. Takahashi K, Takahashi H, Naito M, Sato T, Kojima M: 1983. Ultrastructural and functional development of macrophages in the dermal tissue of rat fetuses. Cell Tissue Res 232:539-552.
51. Vadas P, Pruzanski W: 1986. Biology of disease: role of secretory phospholipase A2 in the pathobiology of disease. Lab Invest 55: 391-404.
52. Volkman A, Chang C, Strausbauch PH, et al.: 1983. Differential effects of chronic monocyte depletion on macrophage populations. Lab Invest 49:291-298.
53. Yamada M, Naito M, Takahashi K: 1990. Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol 47:195-205.
54. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al.: 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095.
55. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M: 1993. Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb 13:331-337.